Buckingham Asset Management LLC boosted its holdings in shares of Clorox Company (The) (NYSE:CLX) by 45.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,823 shares of the company’s stock after purchasing an additional 888 shares during the quarter. Buckingham Asset Management LLC’s holdings in Clorox Company (The) were worth $372,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of CLX. Janus Henderson Group PLC boosted its position in Clorox Company (The) by 8,008.5% during the second quarter. Janus Henderson Group PLC now owns 1,323,475 shares of the company’s stock worth $176,340,000 after purchasing an additional 1,307,153 shares in the last quarter. Vanguard Group Inc. boosted its position in Clorox Company (The) by 2.6% during the second quarter. Vanguard Group Inc. now owns 14,534,634 shares of the company’s stock worth $1,936,595,000 after purchasing an additional 369,918 shares in the last quarter. APG Asset Management N.V. boosted its position in Clorox Company (The) by 30.9% during the third quarter. APG Asset Management N.V. now owns 1,301,915 shares of the company’s stock worth $171,736,000 after purchasing an additional 307,700 shares in the last quarter. Ameriprise Financial Inc. boosted its position in Clorox Company (The) by 24.6% during the second quarter. Ameriprise Financial Inc. now owns 1,341,272 shares of the company’s stock worth $178,433,000 after purchasing an additional 265,200 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its position in Clorox Company (The) by 24.5% during the second quarter. Renaissance Technologies LLC now owns 1,341,400 shares of the company’s stock worth $178,728,000 after purchasing an additional 263,700 shares in the last quarter. Institutional investors own 71.58% of the company’s stock.

Clorox Company (NYSE:CLX) traded up $1.76 during trading hours on Friday, hitting $134.54. The company had a trading volume of 690,100 shares, compared to its average volume of 815,937. Clorox Company has a 12-month low of $112.28 and a 12-month high of $141.76. The company has a debt-to-equity ratio of 3.02, a quick ratio of 0.77 and a current ratio of 1.10. The firm has a market capitalization of $17,210.00, a PE ratio of 23.92, a PEG ratio of 3.62 and a beta of 0.39.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings results on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, beating the consensus estimate of $1.41 by $0.05. Clorox Company (The) had a return on equity of 161.59% and a net margin of 11.84%. The firm had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same quarter last year, the firm earned $1.36 earnings per share. The business’s revenue for the quarter was up 4.0% on a year-over-year basis. sell-side analysts forecast that Clorox Company will post 5.58 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be issued a $0.84 dividend. The ex-dividend date is Tuesday, January 23rd. This represents a $3.36 annualized dividend and a dividend yield of 2.50%. Clorox Company (The)’s dividend payout ratio is presently 61.65%.

In related news, SVP Matthew T. Laszlo sold 20,051 shares of the stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the sale, the senior vice president now owns 10,896 shares of the company’s stock, valued at $1,421,492.16. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Jon M. Balousek sold 9,223 shares of the stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total value of $1,280,798.01. Following the completion of the sale, the senior vice president now directly owns 20,614 shares of the company’s stock, valued at approximately $2,862,666.18. The disclosure for this sale can be found here. In the last ninety days, insiders sold 41,293 shares of company stock valued at $5,560,303. Insiders own 1.00% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://www.watchlistnews.com/clorox-company-the-clx-holdings-boosted-by-buckingham-asset-management-llc/1709936.html.

A number of equities analysts have issued reports on the company. Jefferies Group LLC reiterated a “hold” rating and set a $137.00 price target (up previously from $136.00) on shares of Clorox Company (The) in a research report on Wednesday, August 9th. Royal Bank Of Canada restated a “hold” rating and issued a $115.00 target price on shares of Clorox Company (The) in a research report on Wednesday, August 2nd. Zacks Investment Research downgraded Clorox Company (The) from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. BidaskClub downgraded Clorox Company (The) from a “sell” rating to a “strong sell” rating in a research report on Monday, July 24th. Finally, BMO Capital Markets restated an “outperform” rating on shares of Clorox Company (The) in a research report on Tuesday, September 12th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the stock. Clorox Company (The) currently has an average rating of “Hold” and an average price target of $128.72.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.